Major depression after breast cancer: a review of epidemiology and treatment

American Cancer Society, 2007

Ganz, 1998, Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors, Recent Results Cancer Res, 152, 396, 10.1007/978-3-642-45769-2_38

Spiegel, 1996, Cancer and depression, Br J Psychiatry Suppl, 109, 10.1192/S0007125000298486

Mitchell, 2007, Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders, J Clin Oncol, 25, 4670, 10.1200/JCO.2006.10.0438

Hegel, 2006, Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer, Cancer, 107, 2924, 10.1002/cncr.22335

Hardman, 1989, The recognition of psychiatric morbidity on a medical oncology ward, J Psychosom Res, 33, 235, 10.1016/0022-3999(89)90051-2

Passik, 1998, Oncologists' recognition of depression in their patients with cancer, J Clin Oncol, 16, 1594, 10.1200/JCO.1998.16.4.1594

Coyne, 2000, Should we screen for depression? Caveats and potential pitfalls, Appl Prev Psychol, 9, 101, 10.1016/S0962-1849(00)80009-8

Gilbody, 2001, Routinely administered questionnaires for depression and anxiety: systematic review, BMJ, 322, 406, 10.1136/bmj.322.7283.406

Pignone, 2002, Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force, Ann Intern Med, 136, 765, 10.7326/0003-4819-136-10-200205210-00013

Dean, 1987, Psychiatric morbidity following mastectomy: preoperative predictors and types of illness, J Psychosom Res, 31, 385, 10.1016/0022-3999(87)90059-6

Fallowfield, 1990, Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial, BMJ, 301, 575, 10.1136/bmj.301.6752.575

Hopwood, 1991, Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires, Br J Cancer, 64, 349, 10.1038/bjc.1991.304

Hopwood, 1991, Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires, Br J Cancer, 64, 353, 10.1038/bjc.1991.305

Love, 1991, Symptoms associated with tamoxifen treatment in postmenopausal women, Arch Intern Med, 151, 1842, 10.1001/archinte.151.9.1842

Goldberg, 1992, Psychological morbidity in the first year after breast surgery, Eur J Surg Oncol, 18, 327

Lee, 1992, Mastectomy or conservation for early breast cancer: psychological morbidity, Eur J Cancer, 28A, 1340, 10.1016/0959-8049(92)90514-3

Pinder, 1993, Psychiatric disorder in patients with advanced breast cancer: prevalence and associated factors, Eur J Cancer, 29A, 524

Ganz, 1998, Life after breast cancer: understanding women's health-related quality of life and sexual functioning, J Clin Oncol, 16, 501, 10.1200/JCO.1998.16.2.501

Wenzel, 1999, Age-related differences in the quality of life of breast carcinoma patients after treatment, Cancer, 86, 1768, 10.1002/(SICI)1097-0142(19991101)86:9<1768::AID-CNCR19>3.0.CO;2-O

Broeckel, 2000, Quality of life after adjuvant chemotherapy for breast cancer, Breast Cancer Res Treat, 62, 141, 10.1023/A:1006401914682

Crivellari, 2000, Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII, J Clin Oncol, 8, 1412, 10.1200/JCO.2000.18.7.1412

Nystedt, 2000, Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer-self-rated physiological effects and symptoms, Acta Oncol, 39, 959, 10.1080/02841860050215945

Akechi, 2001, Biomedical and psychosocial determinants of psychiatric morbidity among postoperative ambulatory breast cancer patients, Breast Cancer Res Treat, 65, 195, 10.1023/A:1010661530585

Morasso, 2001, Predicting mood disorders in breast cancer patients, Eur J Cancer, 37, 216, 10.1016/S0959-8049(00)00390-7

Gallagher, 2002, Appraisal and psychological distress six months after diagnosis of breast cancer, Br J Health Psychol, 7, 365, 10.1348/135910702760213733

Rakovitch, 2003, A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer, Breast Cancer Res Treat, 77, 285, 10.1023/A:1021853302033

Ganz, 2004, Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial, J Natl Cancer Inst, 96, 376, 10.1093/jnci/djh060

Schou, 2004, Pessimism as a predictor of emotional morbidity one year following breast cancer surgery, Psychooncology, 13, 309, 10.1002/pon.747

Golden-Kreutz, 2004, Depressive symptoms after breast cancer surgery: relationships with global, cancer-related, and life event stress, Psychooncology, 13, 211, 10.1002/pon.736

Aukst-Margetic, 2005, Religiosity, depression and pain in patients with breast cancer, Gen Hosp Psychiatry, 27, 250, 10.1016/j.genhosppsych.2005.04.004

Roscoe, 2005, Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy, Breast Cancer Res Treat, 89, 243, 10.1007/s10549-004-2175-1

Burgess, 2005, Depression and anxiety in women with early breast cancer: five year observational cohort study, BMJ, 330, 702, 10.1136/bmj.38343.670868.D3

Yen, 2006, Quality of life, depression, and stress in breast cancer women outpatients receiving active therapy in Taiwan, Psychiatry Clin Neurosci, 60, 147, 10.1111/j.1440-1819.2006.01479.x

Mehnert, 2007, Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: a prospective study, Psychooncology, 16, 181, 10.1002/pon.1057

Schagen, 1999, Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma, Cancer, 85, 640, 10.1002/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G

Leedham, 1999, Psychosocial concerns and quality of life in breast cancer survivors, Cancer Invest, 17, 342, 10.3109/07357909909032876

Kissane, 2004, Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis, Aust N Z J Psychiatry, 38, 320, 10.1080/j.1440-1614.2004.01358.x

Ell, 2005, Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer, J Clin Oncol, 23, 3052, 10.1200/JCO.2005.08.041

Rowland, 1999, Anxiety and the blues after breast cancer: how common are they?, CNS Spectr, 4, 40, 10.1017/S1092852900012359

Compas, 1999, Adjustment to breast cancer: age-related differences in coping and emotional distress, Breast Cancer Res Treat, 54, 195, 10.1023/A:1006164928474

van Dam, 1998, Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy, J Natl Cancer Inst, 90, 210, 10.1093/jnci/90.3.210

Longman, 1999, Side-effects burden, psychological adjustment, and life quality in women with breast cancer: pattern of association over time, Oncol Nurs Forum, 26, 909

Couzi, 1995, Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy, J Clin Oncol, 13, 2737, 10.1200/JCO.1995.13.11.2737

Saykin, 2003, Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives, Semin Clin Neuropsychiatry, 8, 201

Cathcart, 1993, Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen, Breast Cancer Res Treat, 27, 277, 10.1007/BF00665698

Thompson, 1999, The relationship between tamoxifen, estrogen, and depressive symptoms, Breast J, 5, 375, 10.1046/j.1524-4741.1999.98085.x

Breuer, 2000, The relationship of tamoxifen with dementia, depression, and dependence in activities of daily living in elderly nursing home residents, Women Health, 31, 71, 10.1300/J013v31n01_05

Day, 1999, Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study, J Clin Oncol, 17, 2659, 10.1200/JCO.1999.17.9.2659

Day, 2001, Tamoxifen and depression: more evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) Randomized Study, J Natl Cancer Inst, 93, 1615, 10.1093/jnci/93.21.1615

Lee, 2007, Tamoxifen treatment and new-onset depression in breast cancer patients, Psychosomatics, 48, 205, 10.1176/appi.psy.48.3.205

McIllmurray, 2001, The psychosocial needs of cancer patients: findings from an observational study, Eur J Cancer Care (Engl), 10, 261, 10.1046/j.1365-2354.2001.00280.x

Green, 1998, Prevalence of posttraumatic stress disorder in women with breast cancer, Psychosomatics, 39, 102, 10.1016/S0033-3182(98)71356-8

Epping-Jordan, 1999, Psychological adjustment in breast cancer: processes of emotional distress, Health Psychol, 18, 315, 10.1037/0278-6133.18.4.315

Osborne, 2003, Age-specific norms and determinants of anxiety and depression in 731 women with breast cancer recruited through a population-based cancer registry, Eur J Cancer, 39, 755, 10.1016/S0959-8049(02)00814-6

Kenne Sarenmalm, 2007, Coping with recurrent breast cancer: predictors of distressing symptoms and health-related quality of life, J Pain Symptom Manage, 34, 24, 10.1016/j.jpainsymman.2006.10.017

Tierney, 1991, Side effects expected and experienced by women receiving chemotherapy for breast cancer, BMJ, 302, 272, 10.1136/bmj.302.6771.272

Williamson, 2000, Extending the activity restriction model of depressed affect: evidence from a sample of breast cancer patients, Health Psychol, 19, 339, 10.1037/0278-6133.19.4.339

Bower, 2000, Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life, J Clin Oncol, 18, 743, 10.1200/JCO.2000.18.4.743

Badger, 2001, Depression burden, self-help interventions, and side effect experience in women receiving treatment for breast cancer, Oncol Nurs Forum, 28, 567

Nail, 2004, My get up and go got up and went: fatigue in people with cancer, J Natl Cancer Inst Monogr, 72, 10.1093/jncimonographs/lgh021

de Jong, 2005, Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy, Ann Oncol, 16, 372, 10.1093/annonc/mdi095

Pasacreta, 1997, Depressive phenomena, physical symptom distress, and functional status among women with breast cancer, Nurs Res, 46, 214, 10.1097/00006199-199707000-00006

Spiegel, 2003, Depression and cancer: mechanisms and disease progression, Biol Psychiatry, 54, 269, 10.1016/S0006-3223(03)00566-3

Reddick, 2005, Examining the influence of coping with pain on depression, anxiety, and fatigue among women with breast cancer, J Psychosoc Oncol, 23, 137, 10.1300/J077v23n02_09

Montgomery, 2004, Presurgery distress and specific response expectancies predict postsurgery outcomes in surgery patients confronting breast cancer, Health Psychol, 23, 381, 10.1037/0278-6133.23.4.381

Patrick, 2004, National Institutes of Health State-of-the-Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15–17, 2002, J Natl Cancer Inst Monogr, 9

Gaston-Johansson, 1999, Fatigue, pain, and depression in pre-autotransplant breast cancer patients, Cancer Pract, 7, 240, 10.1046/j.1523-5394.1999.75008.x

Dodd, 2004, Occurrence of symptom clusters, J Natl Cancer Inst Monogr, 76, 10.1093/jncimonographs/lgh008

Fleishman, 2004, Treatment of symptom clusters: pain, depression, and fatigue, J Natl Cancer Inst Monogr, 1, 119, 10.1093/jncimonographs/lgh028

Savard, 2005, Randomized study on the efficacy of cognitive–behavioral therapy for insomnia secondary to breast cancer, Part I: Sleep and psychological effects, J Clin Oncol, 23, 6083, 10.1200/JCO.2005.09.548

Loprinzi, 2000, Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial, Lancet, 356, 2059, 10.1016/S0140-6736(00)03403-6

Aapro, 1999, Depression in breast cancer patients: the need for treatment, Ann Oncol, 10, 627, 10.1023/A:1008328005050

Dhodapkar, 1996, Prognostic factors in elderly women with metastatic breast cancer treated with tamoxifen: an analysis of patients entered on four prospective clinical trials, Cancer, 77, 683, 10.1002/(SICI)1097-0142(19960215)77:4<683::AID-CNCR14>3.0.CO;2-X

Speer, 2005, Study of sexual functioning determinants in breast cancer survivors, Breast J, 11, 440, 10.1111/j.1075-122X.2005.00131.x

Hjerl, 2003, Depression as a prognostic factor for breast cancer mortality, Psychosomatics, 44, 24, 10.1176/appi.psy.44.1.24

Stommel, 2002, Depression and functional status as predictors of death among cancer patients, Cancer, 94, 2719, 10.1002/cncr.10533

Massie, 2004, Prevalence of depression in patients with cancer, J Natl Cancer Inst Monogr, 57, 10.1093/jncimonographs/lgh014

Colleoni, 2000, Depression and degree of acceptance of adjuvant cytotoxic drugs, Lancet, 356, 1326, 10.1016/S0140-6736(00)02821-X

Ayres, 1994, Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients, J Psychosom Res, 38, 393, 10.1016/0022-3999(94)90100-7

Bui, 2005, Relationship of depression to patient satisfaction: findings from the barriers to breast cancer study, Breast Cancer Res Treat, 89, 23, 10.1007/s10549-004-1005-9

DiMatteo, 2000, Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence, Arch Intern Med, 160, 2101, 10.1001/archinte.160.14.2101

Williamson, 1999, Medical and psychosocial predictors of breast cancer treatment decisions, 69

Rowland, 1998, Breast cancer, 380

Sherwin, 1997, Estrogen effects on cognition in menopausal women, Neurology, 48, S21, 10.1212/WNL.48.5_Suppl_7.21S

McLay, 2003, Nulliparity and late menopause are associated with decreased cognitive decline, J Neuropsychiatry Clin Neurosci, 15, 161, 10.1176/appi.neuropsych.15.2.161

Butters, 2000, Changes in cognitive functioning following treatment of late-life depression, Am J Psychiatry, 157, 1949, 10.1176/appi.ajp.157.12.1949

Kuny, 1995, Cognitive performance in patients recovering from depression, Psychopathology, 28, 190, 10.1159/000284922

Lu, 2003, BDNF and activity-dependent synaptic modulation, Learn Mem, 10, 86, 10.1101/lm.54603

Lee, 2007, Decreased plasma BDNF level in depressive patients, J Affect Disord, 101, 239, 10.1016/j.jad.2006.11.005

Karege, 2005, Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity, Biol Psychiatry, 57, 1068, 10.1016/j.biopsych.2005.01.008

Post, 2007, Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications, J Psychiatr Res, 41, 979, 10.1016/j.jpsychires.2006.09.009

Castellon, 2004, Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen, J Clin Exp Neuropsychol, 26, 955, 10.1080/13803390490510905

Poppelreuter, 2004, Cognitive dysfunction and subjective complaints of cancer patients. a cross-sectional study in a cancer rehabilitation centre, Eur J Cancer, 40, 43, 10.1016/j.ejca.2003.08.001

Scheibel, 2004, Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy, J Neuropsychiatry Clin Neurosci, 16, 185, 10.1176/appi.neuropsych.16.2.185

Olin, 2001, Cognitive function after systemic therapy for breast cancer, Oncology (Huntingt), 15, 613

Vardy, 2006, Assessing cognitive function in cancer patients, Support Care Cancer, 14, 1111, 10.1007/s00520-006-0037-6

Hermelink, 2007, Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study, Cancer, 109, 1905, 10.1002/cncr.22610

Schagen, 2006, Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients, J Natl Cancer Inst, 98, 1742, 10.1093/jnci/djj470

Tchen, 2003, Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer, J Clin Oncol, 21, 4175, 10.1200/JCO.2003.01.119

Brezden, 2000, Cognitive function in breast cancer patients receiving adjuvant chemotherapy, J Clin Oncol, 18, 2695, 10.1200/JCO.2000.18.14.2695

Schagen, 2001, Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function, J Neurooncol, 51, 159, 10.1023/A:1010635229762

Paganini-Hill, 2000, Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen, Breast Cancer Res Treat, 64, 165, 10.1023/A:1006426132338

Jenkins, 2004, Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study, Psychooncology, 13, 61, 10.1002/pon.709

Rossi Ferrario, 2003, A comparative assessment of psychological and psychosocial characteristics of cancer patients and their caregivers, Psychooncology, 12, 1, 10.1002/pon.626

Blanchard, 1997, The crisis of cancer: psychological impact on family caregivers, Oncology (Huntingt), 11, 189

Grunfeld, 2004, Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers, CMAJ, 170, 1795, 10.1503/cmaj.1031205

Pitceathly, 2003, The psychological impact of cancer on patients' partners and other key relatives: a review, Eur J Cancer, 39, 1517, 10.1016/S0959-8049(03)00309-5

Wagner, 2006, Quality of life of husbands of women with breast cancer, Psychooncology, 15, 109, 10.1002/pon.928

Osborn, 2007, The psychosocial impact of parental cancer on children and adolescents: a systematic review, Psychooncology, 16, 101, 10.1002/pon.1113

Gilbar, 2002, Parent caregiver adjustment to cancer of an adult child, J Psychosom Res, 52, 295, 10.1016/S0022-3999(01)00259-8

Gilbar, 1999, Gender as a predictor of burden and psychological distress of elderly husbands and wives of cancer patients, Psychooncology, 8, 287, 10.1002/(SICI)1099-1611(199907/08)8:4<287::AID-PON385>3.0.CO;2-W

Andrews, 2001, Caregiver burden and symptom distress in people with cancer receiving hospice care, Oncol Nurs Forum, 28, 1469

Gilbar, 2000, The relationship between adult cancer patients' adjustment to their illness and that of their parents, Fam Syst Health, 18, 5, 10.1037/h0091850

Chen, 2004, Impact of cancer patients' quality of life on that of spouse caregivers, Support Care Cancer, 12, 469, 10.1007/s00520-004-0636-z

Cohen, 2005, Mothers with breast cancer and their adult daughters: the relationship between mothers' reaction to breast cancer and their daughters' emotional and neuroimmune status, Psychosom Med, 67, 64, 10.1097/01.psy.0000151746.36540.6e

Valdimarsdottir, 2002, The unrecognised cost of cancer patients' unrelieved symptoms: a nationwide follow-up of their surviving partners, Br J Cancer, 86, 1540, 10.1038/sj.bjc.6600271

Aarsland, 1999, Mental symptoms in Parkinson's disease are important contributors to caregiver distress, Int J Geriatr Psychiatry, 14, 866, 10.1002/(SICI)1099-1166(199910)14:10<866::AID-GPS38>3.0.CO;2-Z

Scazufca, 2002, Caregiver burden in an elderly population with depression in Sao Paulo, Brazil, Soc Psychiatry Psychiatr Epidemiol, 37, 416, 10.1007/s00127-002-0571-6

Cummings, 1994, Maternal depression and child development, J Child Psychol Psychiatry, 35, 73, 10.1111/j.1469-7610.1994.tb01133.x

Davis Kirsch, 2003, Making the most of the moment: when a child's mother has breast cancer, Cancer Nurs, 26, 47, 10.1097/00002820-200302000-00007

Ballin, 1997, The antidepressant fluvoxamine increases natural killer cell counts in cancer patients, Isr J Med Sci, 33, 720

Razavi, 1999, Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot study, J Int Med Res, 27, 264, 10.1177/030006059902700602

Musselman, 2006, A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression, J Clin Psychiatry, 67, 288, 10.4088/JCP.v67n0217

Torta, 2007, Sertraline effectiveness and safety in depressed oncological patients, Support Care Cancer

Costa, 1985, Efficacy and safety of mianserin in the treatment of depression of women with cancer, Acta Psychiatr Scand Suppl, 320, 85, 10.1111/j.1600-0447.1985.tb08081.x

van Heeringen, 1996, Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin, Br J Psychiatry, 169, 440, 10.1192/bjp.169.4.440

Fisch, 2003, Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group, J Clin Oncol, 21, 1937, 10.1200/JCO.2003.08.025

Morrow, 2003, Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program, J Clin Oncol, 21, 4635, 10.1200/JCO.2003.04.070

Razavi, 1996, The effect of fluoxetine on anxiety and depression symptoms in cancer patients, Acta Psychiatr Scand, 94, 205, 10.1111/j.1600-0447.1996.tb09850.x

Holland, 1998, A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer, Psychooncology, 7, 291, 10.1002/(SICI)1099-1611(199807/08)7:4<291::AID-PON361>3.3.CO;2-L

Moslinger-Gehmayr, 2000, A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression, Zentralbl Gynakol, 122, 195

Thompson, 2000, Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology, Psychosomatics, 41, 356, 10.1176/appi.psy.41.4.356

Pezzella, 2001, Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline, Breast Cancer Res Treat, 70, 1, 10.1023/A:1012518831494

Grassi, 2004, Effect of reboxetine on major depressive disorder in breast cancer patients: an open-label study, J Clin Psychiatry, 65, 515, 10.4088/JCP.v65n0410

Maguire, 1985, Treatment of depression in cancer patients, Acta Psychiatr Scand Suppl, 320, 81, 10.1111/j.1600-0447.1985.tb08080.x

Meyer, 1995, Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments, Health Psychol, 14, 101, 10.1037/0278-6133.14.2.101

Fawzy, 1999, Psychosocial interventions for patients with cancer: what works and what doesn't, Eur J Cancer, 35, 1559, 10.1016/S0959-8049(99)00191-4

Edwards, 2004, Psychological interventions for women with metastatic breast cancer, Cochrane Database Syst Rev, CD004253

Sheard, 1999, The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses, Br J Cancer, 80, 1770, 10.1038/sj.bjc.6690596

Anderson, 2002, Biobehavioral outcomes following psychological interventions for cancer patients, J Consult Clin Psychol, 70, 590, 10.1037/0022-006X.70.3.590

Chujo, 2005, A feasibility study of psychosocial group intervention for breast cancer patients with first recurrence, Support Care Cancer, 13, 503, 10.1007/s00520-004-0733-z

Rehse, 2003, Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies, Patient Educ Couns, 50, 179, 10.1016/S0738-3991(02)00149-0

Jacobsen, 2006

Devine, 1995, The effects of psychoeducational care provided to adults with cancer: meta-analysis of 116 studies, Oncol Nurs Forum, 22, 1369

Ross, 2002, Mind and cancer: does psychosocial intervention improve survival and psychological well-being?, Eur J Cancer, 38, 1447, 10.1016/S0959-8049(02)00126-0

Fisch, 2004, Treatment of depression in cancer, J Natl Cancer Inst Monogr, 1, 105, 10.1093/jncimonographs/lgh011

Newell, 2002, Systematic review of psychological therapies for cancer patients: overview and recommendations for future research, J Natl Cancer Inst, 94, 558, 10.1093/jnci/94.8.558

Classen, 2001, Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial, Arch Gen Psychiatry, 58, 494, 10.1001/archpsyc.58.5.494

Manne, 2004, Couples' support-related communication, psychological distress, and relationship satisfaction among women with early stage breast cancer, J Consult Clin Psychol, 72, 660, 10.1037/0022-006X.72.4.660

Lepore, 2006, Psychological interventions for distress in cancer patients: a review of reviews, Ann Behav Med, 32, 85, 10.1207/s15324796abm3202_2

Williams, 2006, The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review, Br J Cancer, 94, 372, 10.1038/sj.bjc.6602949

Savard, 2006, Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: psychological and immunological effects, Palliat Support Care, 4, 219, 10.1017/S1478951506060305

Greer, 1992, Adjuvant psychological therapy for patients with cancer: a prospective randomised trial, BMJ, 304, 675, 10.1136/bmj.304.6828.675

Antoni, 2001, Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer, Health Psychol, 20, 20, 10.1037/0278-6133.20.1.20

Kissane, 2003, Cognitive-existential group psychotherapy for women with primary breast cancer: a randomised controlled trial, Psychooncology, 12, 532, 10.1002/pon.683

Kissane, 2007, Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial, Psychooncology, 16, 277, 10.1002/pon.1185

Burton, 1995, A randomised controlled trial of preoperative psychology preparation for mastectomy, Psychooncology, 4, 1, 10.1002/pon.2960040102

Gotay, 2007, Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence, J Clin Oncol, 25, 2093, 10.1200/JCO.2006.07.4674

McDaniel, 1995, Depression in patients with cancer. Diagnosis, biology, and treatment, Arch Gen Psychiatry, 52, 89, 10.1001/archpsyc.1995.03950140007002

Halbreich, 1995, Estrogen augments serotonergic activity in postmenopausal women, Biol Psychiatry, 37, 434, 10.1016/0006-3223(94)00181-2

Pearlstein, 1995, Hormones and depression: what are the facts about premenstrual syndrome, menopause, and hormone replacement therapy?, Am J Obstet Gynecol, 173, 646, 10.1016/0002-9378(95)90297-X

Melzer, 1990, Role of serotonin in depression, Ann N Y Acad Sci, 600, 486, 10.1111/j.1749-6632.1990.tb16904.x

Gonzales, 1993, Blood serotonin levels in postmenopausal women: effects of age and serum oestradiol levels, Maturitas, 17, 23, 10.1016/0378-5122(93)90120-7

Schmidt, 1991, Menopause-related affective disorders: a justification for further study, Am J Psychiatry, 148, 844, 10.1176/ajp.148.7.844

Weissman, 1977, Assessing depressive symptoms in five psychiatric populations: a validation study, Am J Epidemiol, 106, 203, 10.1093/oxfordjournals.aje.a112455

Kessler, 1993, Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence, J Affect Disord, 29, 85, 10.1016/0165-0327(93)90026-G

Freeman, 2004, Hormones and menopausal status as predictors of depression in women in transition to menopause, Arch Gen Psychiatry, 61, 62, 10.1001/archpsyc.61.1.62

Young, 2000, Alteration in the hypothalamic-pituitary-ovarian axis in depressed women, Arch Gen Psychiatry, 57, 1157, 10.1001/archpsyc.57.12.1157

Harlow, 2003, Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles, Arch Gen Psychiatry, 60, 29, 10.1001/archpsyc.60.1.29

Sumner, 1999, Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement, Brain Res Mol Brain Res, 73, 119, 10.1016/S0169-328X(99)00243-0

Fallowfield, 2006, Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer, J Clin Oncol, 24, 910, 10.1200/JCO.2005.03.3654

Whelan, 2005, Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women, J Clin Oncol, 23, 6931, 10.1200/JCO.2005.11.181

Fallowfield, 2004, Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial, J Clin Oncol, 22, 4261, 10.1200/JCO.2004.08.029

Mathias, 2006, An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer, Ann Oncol, 17, 1792, 10.1093/annonc/mdl304

Cleeland, 2003, Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms, Cancer, 97, 2919, 10.1002/cncr.11382

Raison, 2003, Depression in cancer: new developments regarding diagnosis and treatment, Biol Psychiatry, 54, 283, 10.1016/S0006-3223(03)00413-X

Bower, 2002, Fatigue and proinflammatory cytokine activity in breast cancer survivors, Psychosom Med, 64, 604, 10.1097/00006842-200207000-00010

Bower, 2007, Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids, Brain Behav Immun, 21, 251, 10.1016/j.bbi.2006.08.001

Nieboer, 2005, Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study, J Clin Oncol, 23, 8296, 10.1200/JCO.2005.10.167

Maes, 1997, Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression, Cytokine, 9, 853, 10.1006/cyto.1997.0238

Maes, 1995, Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression, J Affect Disord, 34, 301, 10.1016/0165-0327(95)00028-L

Licinio, 1999, The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection, Mol Psychiatry, 4, 317, 10.1038/sj.mp.4000586

Musselman, 2001, Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings, Am J Psychiatry, 158, 1252, 10.1176/appi.ajp.158.8.1252

Dantzer, 2001, Cytokine-induced sickness behavior: where do we stand?, Brain Behav Immun, 15, 7, 10.1006/brbi.2000.0613

Kronfol, 2000, Cytokines and the brain: implications for clinical psychiatry, Am J Psychiatry, 157, 683, 10.1176/appi.ajp.157.5.683

Capuron, 2003, Cytokines and depression: the need for a new paradigm, Brain Behav Immun, 17, S119, 10.1016/S0889-1591(02)00078-8

Schiepers, 2005, Cytokines and major depression, Prog Neuropsychopharmacol Biol Psychiatry, 29, 201, 10.1016/j.pnpbp.2004.11.003

Musselman, 2001, Paroxetine for the prevention of depression induced by high-dose interferon alfa, N Engl J Med, 344, 961, 10.1056/NEJM200103293441303

Capuron, 2002, Treatment of cytokine-induced depression, Brain Behav Immun, 16, 575, 10.1016/S0889-1591(02)00007-7

Sluzewska, 1995, Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine, Ann N Y Acad Sci, 762, 474, 10.1111/j.1749-6632.1995.tb32372.x

Wolkowitz, 1999, Treatment of depression with antiglucocorticoid drugs, Psychosom Med, 61, 698, 10.1097/00006842-199909000-00011

Williams, 2000, Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults, JAMA, 284, 1519, 10.1001/jama.284.12.1519

Coyne, 2004, Distress, psychiatric morbidity, and prescriptions for psychotropic medication in a breast cancer waiting room sample, Gen Hosp Psychiatry, 26, 121, 10.1016/j.genhosppsych.2003.08.012

Katon, 1992, Adequacy and duration of antidepressant treatment in primary care, Med Care, 30, 67, 10.1097/00005650-199201000-00007

Keller, 2000, A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression, N Engl J Med, 342, 1462, 10.1056/NEJM200005183422001

Loprinzi, 2002, Phase III evaluation of fluoxetine for treatment of hot flashes, J Clin Oncol, 20, 1578, 10.1200/JCO.20.6.1578

Stearns, 2000, A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors, Ann Oncol, 11, 17, 10.1023/A:1008382706068

Soares, 2003, Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms, J Clin Psychiatry, 64, 473, 10.4088/JCP.v64n0419

Kimmick, 2006, Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen, Breast J, 12, 114, 10.1111/j.1075-122X.2006.00218.x

Stearns, 2003, Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial, JAMA, 289, 2827, 10.1001/jama.289.21.2827

Gordon, 2006, Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population, Menopause, 13, 568, 10.1097/01.gme.0000196595.82452.ca

Jin, 2005, CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment, J Natl Cancer Inst, 97, 30, 10.1093/jnci/dji005

Coope, 1981, Is oestrogen therapy effective in the treatment of menopausal depression?, J R Coll Gen Pract, 31, 134

Morrison, 2004, Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial, Biol Psychiatry, 55, 406, 10.1016/j.biopsych.2003.08.011

Haines, 2003, A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese women, Maturitas, 44, 207, 10.1016/S0378-5122(02)00340-7

Schneider, 2001, Estrogen replacement therapy and antidepressant response to sertraline in older depressed women, Am J Geriatr Psychiatry, 9, 393, 10.1176/appi.ajgp.9.4.393

Schneider, 1997, Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group, Am J Geriatr Psychiatry, 5, 97, 10.1097/00019442-199700520-00002

Shapira, 1985, Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives, Biol Psychiatry, 20, 576, 10.1016/0006-3223(85)90031-9

Amsterdam, 1999, Fluoxetine efficacy in menopausal women with and without estrogen replacement, J Affect Disord, 55, 11, 10.1016/S0165-0327(98)00203-1

Hewitt, 2006

Hewitt, 2004

1999, NCCN practice guidelines for the management of psychosocial distress. National Comprehensive Cancer Network, Oncology (Huntingt), 13, 113

Gilbody, 2006, Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes, Arch Intern Med, 166, 2314, 10.1001/archinte.166.21.2314